• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中药恒清Ⅱ方对阿尔茨海默病的治疗作用及代谢谱

Therapeutic Effects and Metabolic Spectrum of Traditional Chinese Medicine Hengqing II Prescription on Alzheimer's Disease.

作者信息

Meng Shengxi, Li Shaopeng, Chen Huize, Deng Chujun, Meng Zeyu, Wang Yimo

机构信息

Department of Traditional Chinese Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China.

Shanghai Sensichip Infotech, Shanghai 200331, China.

出版信息

Evid Based Complement Alternat Med. 2022 Aug 2;2022:5912396. doi: 10.1155/2022/5912396. eCollection 2022.

DOI:10.1155/2022/5912396
PMID:35958907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9363161/
Abstract

Alzheimer's disease (AD) seriously damages elders' social and daily abilities around the world. Traditional Chinese medicine (TCM), a rich drug resource bank, could help research AD. In order to explore the role of TCM in AD treatment, 86 AD patients were recruited from the hospital, then treated with Hengqing II prescription and donepezil hydrochloride. The cognitive and serum lipid levels were investigated before and after treatment. The patient's urine was collected after three months of treatment. Metabolites in the urine samples were extracted with methanol and detected on the UHPLC-MS platform. Results proved that Hengqing II can improve cognitive levels and reduce the levels of Hcy, D-D, FIB, Apo B, TC, and LDL-C compared with donepezil hydrochloride ( < 0.05). The results of multivariate statistical analysis revealed that the metabolism of HQII was significantly different compared with Control groups. A total of 66 differential metabolites were found in this comparison (50 were down-regulated and 16 were up-regulated). Four amino acid pathways and one linoleic acid pathway were found through these metabolites. After receiver operating characteristic analysis, it was suggested that palmitic acid, palmitoleic acid, linoleic acid, oleic acid, SAH, and methionine can be used as biomarkers for treating AD, while the effects of daidzein, genistein, and naringenin on the treatment of AD need to be further studied.

摘要

阿尔茨海默病(AD)在全球范围内严重损害老年人的社交和日常生活能力。中药(TCM)作为一个丰富的药物资源库,有助于AD的研究。为了探讨中药在AD治疗中的作用,从医院招募了86例AD患者,然后用恒清II方和盐酸多奈哌齐进行治疗。治疗前后对认知和血脂水平进行了调查。治疗三个月后收集患者尿液。尿液样本中的代谢物用甲醇提取,并在超高效液相色谱-质谱平台上进行检测。结果证明,与盐酸多奈哌齐相比,恒清II能提高认知水平,降低同型半胱氨酸、D-二聚体、纤维蛋白原、载脂蛋白B、总胆固醇和低密度脂蛋白胆固醇水平(<0.05)。多变量统计分析结果显示,与对照组相比,恒清II的代谢存在显著差异。在该比较中总共发现了66种差异代谢物(50种下调,16种上调)。通过这些代谢物发现了四条氨基酸途径和一条亚油酸途径。经过受试者工作特征分析,提示棕榈酸、棕榈油酸、亚油酸、油酸、S-腺苷高半胱氨酸和蛋氨酸可作为治疗AD的生物标志物,而大豆苷元、染料木黄酮和柚皮苷对AD治疗的作用有待进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220f/9363161/5851c3090d31/ECAM2022-5912396.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220f/9363161/101e54cdee85/ECAM2022-5912396.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220f/9363161/1a963efdfcbd/ECAM2022-5912396.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220f/9363161/064832907f3a/ECAM2022-5912396.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220f/9363161/5500af494ab9/ECAM2022-5912396.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220f/9363161/5851c3090d31/ECAM2022-5912396.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220f/9363161/101e54cdee85/ECAM2022-5912396.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220f/9363161/1a963efdfcbd/ECAM2022-5912396.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220f/9363161/064832907f3a/ECAM2022-5912396.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220f/9363161/5500af494ab9/ECAM2022-5912396.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220f/9363161/5851c3090d31/ECAM2022-5912396.005.jpg

相似文献

1
Therapeutic Effects and Metabolic Spectrum of Traditional Chinese Medicine Hengqing II Prescription on Alzheimer's Disease.中药恒清Ⅱ方对阿尔茨海默病的治疗作用及代谢谱
Evid Based Complement Alternat Med. 2022 Aug 2;2022:5912396. doi: 10.1155/2022/5912396. eCollection 2022.
2
Metabolomics Deciphering the Potential Biomarkers of Hengqing I Prescription against Vascular Dementia.代谢组学解析恒清I方抗血管性痴呆的潜在生物标志物
Evid Based Complement Alternat Med. 2022 Mar 30;2022:1636145. doi: 10.1155/2022/1636145. eCollection 2022.
3
Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.载脂蛋白 E4 血清浓度可提高药物治疗的阿尔茨海默病患者与药物治疗的帕金森病患者以及年龄匹配的正常对照者诊断的灵敏度和特异性。
Curr Alzheimer Res. 2012 Dec;9(10):1149-67. doi: 10.2174/156720512804142868.
4
[Chinese herbal medicine for patients with mild to moderate Alzheimer disease based on syndrome differentiation: a randomized controlled trial].基于辨证论治的中药治疗轻中度阿尔茨海默病患者:一项随机对照试验
Zhong Xi Yi Jie He Xue Bao. 2012 Jul;10(7):766-76. doi: 10.3736/jcim20120707.
5
Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease.基于网络药理学分析和血清代谢组学探讨补肾填髓方改善阿尔茨海默病认知功能的作用机制
J Ethnopharmacol. 2020 Mar 1;249:112371. doi: 10.1016/j.jep.2019.112371. Epub 2019 Nov 1.
6
Effect of donepezil on Hcy level in serum of Alzheimer's disease patients and correlation analysis of Hcy and dyssomnia.多奈哌齐对阿尔茨海默病患者血清同型半胱氨酸水平的影响及同型半胱氨酸与失眠的相关性分析
Exp Ther Med. 2019 Feb;17(2):1395-1399. doi: 10.3892/etm.2018.7071. Epub 2018 Dec 7.
7
High-throughput lipidomics characterize key lipid molecules as potential therapeutic targets of Kaixinsan protects against Alzheimer's disease in APP/PS1 transgenic mice.高通量脂质组学鉴定关键脂质分子作为抗衰益智方(Kaixinsan)防治 APP/PS1 转基因小鼠阿尔茨海默病的潜在治疗靶点。
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Aug 15;1092:286-295. doi: 10.1016/j.jchromb.2018.06.032. Epub 2018 Jun 18.
8
[Effect of electroacupuncture at governor vessel on learning-memory ability and serum level of APP, Aβ in patients with Alzheimer's disease].[督脉电针治疗对阿尔茨海默病患者学习记忆能力及血清APP、Aβ水平的影响]
Zhongguo Zhen Jiu. 2020 Apr 12;40(4):375-8. doi: 10.13703/j.0255-2930.20190728-0003.
9
Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4: A double-blind, randomized, placebo-controlled crossover trial.中链甘油三酯改善了携带APOE4的轻度至中度阿尔茨海默病患者的认知功能和脂质代谢组学:一项双盲、随机、安慰剂对照交叉试验。
Clin Nutr. 2020 Jul;39(7):2092-2105. doi: 10.1016/j.clnu.2019.10.017. Epub 2019 Oct 22.
10
Rapid discovery of quality-markers from Kaixin San using chinmedomics analysis approach.基于中医组学分析策略的开心散质量标志物快速发现。
Phytomedicine. 2019 Feb 15;54:371-381. doi: 10.1016/j.phymed.2017.12.014. Epub 2017 Dec 18.

引用本文的文献

1
Chuanxiong Renshen Decoction Inhibits Alzheimer's Disease Neuroinflammation by Regulating PPARγ/NF-κB Pathway.川芎人参汤通过调节 PPARγ/NF-κB 通路抑制阿尔茨海默病神经炎症。
Drug Des Devel Ther. 2024 Jul 24;18:3209-3232. doi: 10.2147/DDDT.S462266. eCollection 2024.

本文引用的文献

1
LPS and palmitic acid Co-upregulate microglia activation and neuroinflammatory response.脂多糖和棕榈酸共同上调小胶质细胞活化和神经炎症反应。
Compr Psychoneuroendocrinol. 2021 Mar 17;6:100048. doi: 10.1016/j.cpnec.2021.100048. eCollection 2021 May.
2
Gastrodin and Vascular Dementia: Advances and Current Perspectives.天麻素与血管性痴呆:研究进展与当前观点
Evid Based Complement Alternat Med. 2022 Apr 12;2022:2563934. doi: 10.1155/2022/2563934. eCollection 2022.
3
Multiple Roles of Paeoniflorin in Alzheimer's Disease.芍药苷在阿尔茨海默病中的多重作用
Evid Based Complement Alternat Med. 2022 Apr 11;2022:2464163. doi: 10.1155/2022/2464163. eCollection 2022.
4
Biofluid-based biomarkers for Alzheimer's disease-related pathologies: An update and synthesis of the literature.基于生物流体的阿尔茨海默病相关病理生物标志物:文献综述与更新。
Alzheimers Dement. 2022 Sep;18(9):1687-1693. doi: 10.1002/alz.12618. Epub 2022 Feb 25.
5
Saponins and flavonoids from Bacopa floribunda plant extract exhibit antioxidant and anti-inflammatory effects on amyloid beta 1-42-induced Alzheimer's disease in BALB/c mice.白花蛇舌草提取物中的皂素和黄酮类化合物对 BALB/c 小鼠淀粉样β 1-42 诱导的阿尔茨海默病具有抗氧化和抗炎作用。
J Ethnopharmacol. 2022 Apr 24;288:114997. doi: 10.1016/j.jep.2022.114997. Epub 2022 Jan 13.
6
Blood-based biomarkers of agitation in Alzheimer's disease: Advances and future prospects.阿尔茨海默病激越的基于血液的生物标志物:进展与未来展望。
Neurochem Int. 2022 Jan;152:105250. doi: 10.1016/j.neuint.2021.105250. Epub 2021 Dec 2.
7
Association between homocysteine levels and cognitive profile in Alzheimer's Disease.同型半胱氨酸水平与阿尔茨海默病认知特征的相关性。
J Clin Neurosci. 2021 Dec;94:250-256. doi: 10.1016/j.jocn.2021.09.033. Epub 2021 Nov 8.
8
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.用于阿尔茨海默病的血液生物标志物:迈向临床应用
Lancet Neurol. 2022 Jan;21(1):66-77. doi: 10.1016/S1474-4422(21)00361-6. Epub 2021 Nov 24.
9
Multiple roles of short-chain fatty acids in Alzheimer disease.短链脂肪酸在阿尔茨海默病中的多重作用。
Nutrition. 2022 Jan;93:111499. doi: 10.1016/j.nut.2021.111499. Epub 2021 Sep 23.
10
Current research status of blood biomarkers in Alzheimer's disease: Diagnosis and prognosis.阿尔茨海默病血液生物标志物的研究现状:诊断与预后。
Ageing Res Rev. 2021 Dec;72:101492. doi: 10.1016/j.arr.2021.101492. Epub 2021 Oct 19.